Device To Preserve And Stabilize Relative Abundances Of Microbial Nucleic Acids In Clinical Samples
Microbiology · 21 CFR 866.2952
A device to preserve and stabilize relative abundances of microbial nucleic acids in clinical samples is a device that consists of a container and reagents intended to stabilize microbial nucleic acids for the subsequent assessment of the relative abundance of microbial nucleic acids (i.e., microbiome) in human specimens by an assay validated for use with the device. The device may also be indicated for sample collection. The device is not intended for preserving morphology or viability of microorganisms.
Recent MDR events
0 adverse event reports on file
No MDR events on file for this product code.
Event type breakdown
No data available.
Most-reported manufacturers
No data available.
Recalls
6 recall events for this product code
- GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Gut Microbiome Test Large
Distribution without premarket approval/clearance.
Z-0778-2026 · View FDA record ↗ - GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Gut Microbiome Test Medium
Distribution without premarket approval/clearance.
Z-0779-2026 · View FDA record ↗ - GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Gut Microbiome Test Mega
Distribution without premarket approval/clearance.
Z-0780-2026 · View FDA record ↗ - GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Gut Microbiome Test Small
Distribution without premarket approval/clearance.
Z-0781-2026 · View FDA record ↗ - GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Gut Microbiome Test XL
Distribution without premarket approval/clearance.
Z-0782-2026 · View FDA record ↗ - GET TESTED INTERNATIONAL ABOpen, ClassifiedDec 1, 2025
Hair Mineral Analysis
Distribution without premarket approval/clearance.
Z-0783-2026 · View FDA record ↗
Registered firms
4 firms currently registered for this product code
510(k) clearances
1 clearances for this product code